The Addiction Medicine Foundation today announced the accreditation of four additional fellowship programs to train addiction medicine physicians. The Foundation has supported the establishment of 40 addiction medicine fellowship training programs to date, based at major medical schools and hospitals across North America.
Developmental psychologist finds adolescents with severe alcohol and other drug (AOD) problems have a low regard for others, as indicated by higher rates of driving under the influence and having unprotected sex with a history of sexually transmitted disease.
A clinical trial from NYU Langone Medical Center and others finds use of long-term, extended-release naltrexone leads to decreases in opioid addiction relapse. Learn more.
The once-a-month drug naltrexone was more effective at preventing drug relapse in ex-prisoners addicted to heroin and other opioids compared to the usual treatment modalities, including counseling and community treatment programs, according to results from a multisite, randomized trial led by researchers at the Center for Studies of Addiction at the Perelman School of Medicine at the University of Pennsylvania and published online today in the New England Journal of Medicine.
Most people know that heroin is a dangerous drug, but its cousins, the legal, pharmaceutical opioids, such as codeine or hydrocodone, must be safe, right?
Experts take an in-depth look into a favorite college pastime by understanding the dangers and risks of alcohol.
In a recent study published in The Journal of Neuroscience, a research team led by Dr. Dorit Ron at the University of California, San Francisco examined whether a single exposure to alcohol can induce memory and behavioral changes that could promote future drinking.
Dr. Palamar and his team of researchers are the first to examine whether ecstasy users are unknowingly or unintentionally using “bath salts” and/or other novel psychoactive drugs.
Psychedelic drugs such as LSD hold promise for palliative care for an aging population, said University of Saskatchewan medical historian Erika Dyck.
With use of synthetic opioid “designer drugs” rising, scientists from The Scripps Research Institute have a new strategy to curb addiction and even prevent fatal overdoses, reporting successful preclinical tests of a vaccine that prevents the synthetic opioid fentanyl from reaching the brain.
